• Home
  • Lifetech Products
  • R & D
  • News
  • Investor Relations
  • About Us
中文
  • Products News
  • Lifetech News
  • Video
  • 30 2023-08

    LifeTech Scientific Corporation...

    LifeTech Scientific Corporation (the “Company” or “Lifetech”), a leading company specialized in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, today announced the unaudited consolidated results of the Company and its subsidiaries (collectively the “Group”) for the six months ended 30 June 2023 (the “Reporting Period”).

  • 30 2023-03

    LifeTech Reports Steady Growth o...

    LifeTech Scientific Corporation (the “Company” or “Lifetech”), a leading company specialized in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, today announced its 2022 annual results.

  • 05 2022-09

    FDA-approved Investigator-initia...

    LifeTech Scientific Corporation (Stock Code: 1302.HK) is pleased to announce that on 30 August 2022, an FDA-approved investigator-initiated pre-market clinical trial of its proprietary LAmbre™ Plus Left Atrial Appendage (LAA) Closure System has obtained medical insurance coverage in the United States

  • 31 2022-08

    LifeTech Scientific Corporation...

    - Revenue increased by 20.4%, net profit attributable to owners of the Company increased by 34.4% after excluding certain non-recurring items

  • 30 2022-03

    LifeTech Scientific Corporation...

    LifeTech Scientific Corporation (LifeTech, 1302.HK), a leading company specialized in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, today announced 2021 annual results.

  • 30 2021-08

    LifeTech Scientific Corporation ...

    LifeTech Scientific Corporation (LifeTech, 01302.HK), a leading company specialized in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, today announced 2021 interim results.

  • 30 2021-03

    LifeTech Scientific Corporation ...

    The leading company specialized in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases —LifeTech Scientific Corporation (the “Company”) and its subsidiaries (the “Group”) announced the audited consolidated results for the year ended 31 December 2020 (the “Reporting Period”).

  • 07 2020-12

    HK$930 Million Proceeds from New...

    On 4 December 2020, LifeTech Scientific Corporation entered into a placement agreement with the Citigroup Global Markets Limited. The Company will place 287,320,000 new shares at the price of HK$3.2368 per placing share.

  • 25 2020-11

    Lifetech Subsidiary Biotyx Medic...

    On 24 November 2020, Biotyx Medical (Shenzhen) Co., Ltd. , a holding subsidiary of Lifetech Scientific,specialized in research, development, manufacture and sales of metal-based bioresorbable medical devices, has successfully introduced series A strategic investors, including IDG Capital and Co-Stone Asset Management.

  • 24 2020-11

    Lifetech Introduced Strategic In...

    On 24 November 2020, LifeTech Scientific Corporation noticed that Central Huijin Investment Ltd. has transacted its entire equity interests in the Company to Hillhouse Capital and GL Capital.

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
Legal Notice|Contact Us||Site Map
-->

Lifetech WeChat

Links

Links...
  • Twitter
  • Linked
  • clhweb
Copyright © 2008-2020 Lifetech Scientific, All rights reserved.